Hamilton, Bermuda, Nov. 21, 2016 --
Golar LNG Partners LP (NASDAQ: GMLP) (the "Partnership") announced today that it has awarded 99,000 options to purchase Partnership common units to Directors and Management of the Partnership under the terms of the Partnership's Long Term Incentive Plan. The issued options have an exercise price of $20.55 per unit, representing the closing price of the common units on November 17, 2016. The exercise price will be adjusted for each time the Partnership pays distributions. One third of recipients' allotted options will vest on November 18, 2017, the second third will vest one year later and the final third will vest on November 18, 2019. The option period is five years.
Hamilton, Bermuda
November 21, 2016
Investor relations enquiries:
Golar Management Limited
Graham Robjohns - + 44 207 063 7900
Stuart Buchanan - + 44 207 063 7900
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 



